APLS Smart Money
Apellis Pharmaceuticals, Inc.
1W: +0.0%
1M: +0.4%
3M: +89.1%
YTD: +58.7%
1Y: +145.7%
3Y: -55.1%
5Y: -9.1%
$41.03
Last traded 2026-05-15 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
🏦 Institutional Activity
Latest: Q2 2026321
Institutions Holding
-82 vs prior
0.0%
Ownership
-105.61%
0
New
0
Increased
314
Reduced
313
Closed
👔 Insider Trades
25 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-05-14 | Dunlop A. Sinclair | director | U-U | 161,567 | $— | $0 | Filing |
| 2026-05-14 | Dolsten Mikael | director | D-Sale to Issuer | 14,312 | $— | $0 | Filing |
| 2026-05-14 | Dunlop A. Sinclair | director | D-Sale to Issuer | 5,744 | $— | $0 | Filing |
| 2026-05-14 | Dunlop A. Sinclair | director | D-Sale to Issuer | 7,961 | $— | $0 | Filing |
| 2026-05-14 | Dunlop A. Sinclair | director | D-Sale to Issuer | 3,544 | $— | $0 | Filing |
| 2026-05-14 | Chopas James George | officer: vp/chief accounting officer | U-U | 65,955 | $— | $0 | Filing |
| 2026-05-14 | Chopas James George | officer: vp/chief accounting officer | A-Grant/Award | 5,625 | $— | $0 | Filing |
| 2026-05-14 | Dunlop A. Sinclair | director | D-Sale to Issuer | 3,062 | $— | $0 | Filing |
| 2026-05-14 | Chopas James George | officer: vp/chief accounting officer | A-Grant/Award | 8,394 | $— | $0 | Filing |
| 2026-05-14 | Chopas James George | officer: vp/chief accounting officer | D-Sale to Issuer | 8,394 | $— | $0 | Filing |
| 2026-05-14 | Chopas James George | officer: vp/chief accounting officer | A-Grant/Award | 16,150 | $— | $0 | Filing |
| 2026-05-14 | Chopas James George | officer: vp/chief accounting officer | A-Grant/Award | 8,075 | $— | $0 | Filing |
| 2026-05-14 | Chopas James George | officer: vp/chief accounting officer | D-Sale to Issuer | 8,075 | $— | $0 | Filing |
| 2026-05-14 | Chopas James George | officer: vp/chief accounting officer | D-Sale to Issuer | 2,406 | $— | $0 | Filing |
| 2026-05-14 | Chopas James George | officer: vp/chief accounting officer | D-Sale to Issuer | 4,156 | $— | $0 | Filing |
| 2026-05-14 | Chopas James George | officer: vp/chief accounting officer | D-Sale to Issuer | 9,444 | $— | $0 | Filing |
| 2026-05-14 | Chopas James George | officer: vp/chief accounting officer | D-Sale to Issuer | 16,150 | $— | $0 | Filing |
| 2026-05-14 | Chopas James George | officer: vp/chief accounting officer | D-Sale to Issuer | 6,250 | $— | $0 | Filing |
| 2026-05-14 | Dolsten Mikael | director | U-U | 14,312 | $— | $0 | Filing |
| 2026-05-14 | MELTZER LESLIE | officer: chief research and development | D-Sale to Issuer | 61,804 | $— | $0 | Filing |
| 2026-05-14 | MELTZER LESLIE | officer: chief research and development | U-U | 107,024 | $— | $0 | Filing |
| 2026-05-14 | MELTZER LESLIE | officer: chief research and development | A-Grant/Award | 22,610 | $— | $0 | Filing |
| 2026-05-14 | MELTZER LESLIE | officer: chief research and development | D-Sale to Issuer | 22,610 | $— | $0 | Filing |
| 2026-05-14 | MELTZER LESLIE | officer: chief research and development | A-Grant/Award | 45,220 | $— | $0 | Filing |
| 2026-05-14 | Chopas James George | officer: vp/chief accounting officer | D-Sale to Issuer | 5,625 | $— | $0 | Filing |
🏛️ Congressional Trades
0 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| No congressional trades found | |||||